RF
NVO

Rossby Financial’s Novo Nordisk NVO Stock Holding History

Rossby Financial’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.6K Buy
482
+42
+10% +$1.99K ﹤0.01% 1049
2025
Q4 		$22.4K Buy
440
+10
+2% +$511 0.01% 702
2025
Q3 		$25.4K Sell
430
-5
-1% -$293 0.01% 660
2025
Q2 		$30K Sell
435
-416
-49% -$28.3K 0.01% 582
2025
Q1 		$52.8K Sell
851
-7,460
-90% -$616K 0.02% 469
2024
Q4 		$715K Buy
+8,311
New +$899K 0.44% 52

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Rossby Financial's NVO Position: Q1 2026 in Review

Rossby Financial increased its Novo Nordisk (NVO) stake by 9.5% in Q1 2026, buying an estimated $1.99K and bringing the position to 482 shares worth $17.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1049.

Rossby Financial first reported a position in NVO in Q4 2024 and has held it in 6 quarters since. The position peaked at $715K in Q4 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Rossby Financial held 482 shares of Novo Nordisk worth $17.6K as of Q1 2026.
  • Rossby Financial bought 42 Novo Nordisk shares in Q1 2026, an estimated $1.99K.
  • Novo Nordisk made up ﹤0.01% of Rossby Financial's portfolio in Q1 2026, its #1049 holding.
  • Rossby Financial first reported a position in Novo Nordisk in Q4 2024 and has held it in 6 quarters since.
  • Rossby Financial's Novo Nordisk position peaked at $715K in Q4 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Rossby Financial's 13F filing for Q1 2026, filed 11 May 2026.